Fluid management in sepsis: The potential beneficial effects of albumin

Journal of Critical Care

Volumn 35, Issue , 2016, Pages 161-167

  Vincent, Jean Louis ^a   De Backer, Daniel ^b   Wiedermann, Christian J ^c  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

Albumin; Colloids; Crystalloids; Microcirculation; Nephrotoxicity; Resuscitation

Indexed keywords

ALBUMIN; AMIKACIN; SODIUM CHLORIDE; ALBUMINOID; COLLOID; CRYSTALLOID; ISOTONIC SOLUTION;

ANTIOXIDANT ACTIVITY; BLEEDING; BLOOD VESSEL PERMEABILITY; BURN; CAPILLARY LEAK SYNDROME; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG SAFETY; EDEMA; FLUID BALANCE; FLUID RESUSCITATION; HUMAN; HYPOALBUMINEMIA; HYPOXEMIA; INFLAMMATION; KIDNEY DISEASE; KIDNEY FUNCTION; LIVER CIRRHOSIS; MICROVASCULATURE; MORTALITY; PERFUSION; PLASMA VOLUME; PLEIOTROPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; REVIEW; SEPSIS; SHOCK; SURVIVAL RATE; VASCULAR ENDOTHELIUM; COLLOID; CRITICAL ILLNESS; FLUID THERAPY; INTENSIVE CARE; PROCEDURES; RESUSCITATION; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; THERAPEUTIC USE;

ALBUMINS; COLLOIDS; CRITICAL CARE; CRITICAL ILLNESS; FLUID THERAPY; HUMANS; HYPOALBUMINEMIA; ISOTONIC SOLUTIONS; RESUSCITATION; SEPSIS; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC;

EID: 84994494304     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2016.04.019     Document Type: Review

References (84)

1. [1] Vincent, J.L., De Backer, D., Circulatory shock. N Engl J Med 369 (2013), 1726–1734.
2. [2] Cecconi, M., De Backer, D., Antonelli, M., Beale, R., Bakker, J., Hofer, C., et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40 (2014), 1795–1815.
3. [3] Zanotti-Cavazzoni, S.L., Guglielmi, M., Parrillo, J.E., Walker, T., Dellinger, R.P., Hollenberg, S.M., Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive Care Med 35 (2009), 748–754.
4. [4] Hollenberg, S.M., Dumasius, A., Easington, C., Colilla, S.A., Neumann, A., Parrillo, J.E., Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med 164 (2001), 891–895.
5. [5] Legrand, M., Bezemer, R., Kandil, A., Demirci, C., Payen, D., Ince, C., The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med 37 (2011), 1534–1542.
6. [6] Correa, T.D., Vuda, M., Blaser, A.R., Takala, J., Djafarzadeh, S., Dunser, M.W., et al. Effect of treatment delay on disease severity and need for resuscitation in porcine fecal peritonitis. Crit Care Med 40 (2012), 2841–2849.
7. [7] Vincent, J.L., Sakr, Y., Sprung, C.L., Ranieri, V.M., Reinhart, K., Gerlach, H., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34 (2006), 344–353.
8. [8] Boyd, J.H., Forbes, J., Nakada, T.A., Walley, K.R., Russell, J.A., Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39 (2011), 259–265.
9. [9] Liu, V., Morehouse, J.W., Soule, J., Whippy, A., Escobar, G.J., Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Ann Am Thorac Soc 10 (2013), 466–473.
10. [10] Murphy, C.V., Schramm, G.E., Doherty, J.A., Reichley, R.M., Gajic, O., Afessa, B., et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest 136 (2009), 102–109.
11. [11] Hoste, E.A., Maitland, K., Brudney, C.S., Mehta, R., Vincent, J.L., Yates, D., et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 113 (2014), 740–747.
12. [12] Finfer, S., Bellomo, R., Boyce, N., French, J., Myburgh, J., Norton, R., A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004), 2247–2256.
13. [13] Perner, A., Haase, N., Guttormsen, A.B., Tenhunen, J., Klemenzson, G., Aneman, A., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 367 (2012), 124–134.
14. [14] Caironi, P., Tognoni, G., Masson, S., Fumagalli, R., Pesenti, A., Romero, M., et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370 (2014), 1412–1421.
15. [15] De Backer, D., Creteur, J., Preiser, J.C., Dubois, M.J., Vincent, J.L., Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166 (2002), 98–104.
16. [16] Chappell, D., Jacob, M., Paul, O., Mehringer, L., Newman, W., Becker, B.F., Impaired glycocalyx barrier properties and increased capillary tube haematocrit. J Physiol 586 (2008), 4585–4586.
17. [17] Wang, Z., Holthoff, J.H., Seely, K.A., Pathak, E., Spencer, H.J. III, Gokden, N., et al. Development of oxidative stress in the peritubular capillary microenvironment mediates sepsis-induced renal microcirculatory failure and acute kidney injury. Am J Pathol 180 (2012), 505–516.
18. [18] De Backer, D., Donadello, K., Sakr, Y., Ospina-Tascon, G., Salgado, D., Scolletta, S., et al. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med 41 (2013), 791–799.
19. [19] Bansch, P., Nelson, A., Ohlsson, T., Bentzer, P., Effect of charge on microvascular permeability in early experimental sepsis in the rat. Microvasc Res 82 (2011), 339–345.
20. [20] Woodcock, T.E., Woodcock, T.M., Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108 (2012), 384–394.
21. [21] Jacob, M., Chappell, D., Reappraising Starling: the physiology of the microcirculation. Curr Opin Crit Care 19 (2013), 282–289.
22. [22] Koomans, H.A., Geers, A.B., Boer, P., Roos, J.C., Dorhout Mees, E.J., A study on the distribution of body fluids after rapid saline expansion in normal subjects and in patients with renal insufficiency: preferential intravascular deposition in renal failure. Clin Sci (Lond) 64 (1983), 153–160.
23. [23] Orbegozo Cortes, D., Gamarano Barros, T., Njimi, H., Vincent, J.L., Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg 120 (2015), 389–402.
24. [24] Ernest, D., Belzberg, A.S., Dodek, P.M., Distribution of normal saline and 5% albumin infusions in cardiac surgical patients. Crit Care Med 29 (2001), 2299–2302.
25. [25] Ernest, D., Belzberg, A.S., Dodek, P.M., Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 27 (1999), 46–50.
26. [26] Margarson, M.P., Soni, N.C., Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients. Br J Anaesth 92 (2004), 821–826.
27. [27] Margarson, M.P., Soni, N.C., Effects of albumin supplementation on microvascular permeability in septic patients. J Appl Physiol 92 (2002), 2139–2145.
28. [28] Bansch, P., Statkevicius, S., Bentzer, P., Plasma volume expansion with 5% albumin compared to Ringer's acetate during normal and increased microvascular permeability in the rat. Anesthesiology 121 (2014), 817–824.
29. [29] Dubois, M.J., Orellana-Jimenez, C., Melot, C., De Backer, D., Berre, J., Leeman, M., et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34 (2006), 2536–2540.
30. [30] Brunkhorst, F.M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 (2008), 125–139.
31. [31] Guidet, B., Martinet, O., Boulain, T., Philippart, F., Poussel, J.F., Maizel, J., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care, 16, 2012, R94.
32. [32] Awad, S., Dharmavaram, S., Wearn, C.S., Dube, M.G., Lobo, D.N., Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine(R)) and 6% hydroxyethyl starch (Voluven(R)) on blood volume. Br J Anaesth 109 (2012), 168–176.
33. [33] Bark, B.P., Persson, J., Grande, P.O., Importance of the infusion rate for the plasma expanding effect of 5% albumin, 6% HES 130/0.4, 4% gelatin, and 0.9% NaCl in the septic rat. Crit Care Med 41 (2013), 857–866.
34. [34] Sakr, Y., Dubois, M.J., De Backer, D., Creteur, J., Vincent, J.L., Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32 (2004), 1825–1831.
35. [35] Edul, V.S., Enrico, C., Laviolle, B., Vazquez, A.R., Ince, C., Dubin, A., Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med 40 (2012), 1443–1448.
36. [36] Ospina-Tascon, G., Neves, A.P., Occhipinti, G., Donadello, K., Buchele, G., Simion, D., et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med 36 (2010), 949–955.
37. [37] Pottecher, J., Deruddre, S., Teboul, J.L., Georger, J.F., Laplace, C., Benhamou, D., et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intensive Care Med 36 (2010), 1867–1874.
38. [38] de Carvalho, H., Dorigo, D., Bouskela, E., Effects of Ringer-acetate and Ringer-dextran solutions on the microcirculation after LPS challenge: observations in the hamster cheek pouch. Shock 15 (2001), 157–162.
39. [39] Horstick, G., Lauterbach, M., Kempf, T., Bhakdi, S., Heimann, A., Horstick, M., et al. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med 30 (2002), 851–855.
40. [40] Steinbauer, M., Guba, M., Buchner, M., Farkas, S., Anthuber, M., Jauch, K.W., Impact of polynitroxylated albumin (PNA) and tempol on ischemia/reperfusion injury: intravital microscopic study in the dorsal skinfold chamber of the Syrian golden hamster. Shock 14 (2000), 163–168.
41. [41] Hoffmann, J.N., Vollmar, B., Laschke, M.W., Inthorn, D., Schildberg, F.W., Menger, M.D., Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 97 (2002), 460–470.
42. [42] Dubin, A., Pozo, M.O., Casabella, C.A., Murias, G., Palizas, F. Jr., Moseinco, M.C., et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care, 25, 2010, 659.e1-8.
43. [43] Pranskunas, A., Koopmans, M., Koetsier, P.M., Pilvinis, V., Boerma, E.C., Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intensive Care Med 39 (2013), 612–619.
44. [44] Chappell, D., Jacob, M., Role of the glycocalyx in fluid management: small things matter. Best Pract Res Clin Anaesthesiol 28 (2014), 227–234.
45. [45] Cabrales, P., Vazquez, B.Y., Tsai, A.G., Intaglietta, M., Microvascular and capillary perfusion following glycocalyx degradation. J Appl Physiol 102 (2007), 2251–2259.
46. [46] Marechal, X., Favory, R., Joulin, O., Montaigne, D., Hassoun, S., Decoster, B., et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 29 (2008), 572–576.
47. [47] Chappell, D., Hofmann-Kiefer, K., Jacob, M., Rehm, M., Briegel, J., Welsch, U., et al. TNF-alpha induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res Cardiol 104 (2009), 78–89.
48. [48] Chappell, D., Brettner, F., Doerfler, N., Jacob, M., Rehm, M., Bruegger, D., et al. Protection of glycocalyx decreases platelet adhesion after ischaemia/reperfusion: an animal study. Eur J Anaesthesiol 31 (2014), 474–481.
49. [49] Torres, L.N., Sondeen, J.L., Ji, L., Dubick, M.A., Filho I, Torres, Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats. J Trauma Acute Care Surg 75 (2013), 759–766.
50. [50] Jacob, M., Bruegger, D., Rehm, M., Welsch, U., Conzen, P., Becker, B.F., Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 104 (2006), 1223–1231.
51. [51] Jacob, M., Paul, O., Mehringer, L., Chappell, D., Rehm, M., Welsch, U., et al. Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 87 (2009), 956–965.
52. [52] Kozar, R.A., Peng, Z., Zhang, R., Holcomb, J.B., Pati, S., Park, P., et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg 112 (2011), 1289–1295.
53. [53] Myburgh, J.A., Finfer, S., Bellomo, R., Billot, L., Cass, A., Gattas, D., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 367 (2012), 1901–1911.
54. [54] Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41 (2013), 580–637.
55. [55] Finfer, S., McEvoy, S., Bellomo, R., McArthur, C., Myburgh, J., Norton, R., Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37 (2011), 86–96.
56. [56] Delaney, A.P., Dan, A., McCaffrey, J., Finfer, S., The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med 39 (2011), 386–391.
57. [57] Vincent, J.L., Navickis, R.J., Wilkes, M.M., Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 32 (2004), 2029–2038.
58. [58] Charpentier, J., Mira, J.P., EARSS study group, Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Med 37:Suppl. 1 (2011), S115–0438 [abst].
59. [59] Wiedermann, C.J., Joannidis, M., Albumin replacement in severe sepsis or septic shock. N Engl J Med, 371, 2014, 83.
60. [60] Patel, A., Laffan, M.A., Waheed, U., Brett, S.J., Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ, 349, 2014, g4561.
61. [61] Rochwerg, B., Alhazzani, W., Sindi, A., Heels-Ansdell, D., Thabane, L., Fox-Robichaud, A., et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 161 (2014), 347–355.
62. [62] Shafer, S.L., Wilkes, M.M., Re: Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. Br Med J, 349, 2014, g4561.
63. [63] Wiedermann, C.J., Double-counted mortality data bias in the 2014 meta-analysis of Patel and coworkers. Br Med J, 349, 2014, g4561.
64. [64] Wiedermann, C.J., Dunzendorfer, S., Gaioni, L.U., Zaraca, F., Joannidis, M., Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care, 14, 2010, R191.
65. [65] Wiedermann, C.J., Wiedermann, W., Joannidis, M., Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 36 (2010), 1657–1665.
66. [66] Bernardi, M., Caraceni, P., Navickis, R.J., Wilkes, M.M., Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials. Hepatology 55 (2012), 1172–1181.
67. [67] Salerno, F., Navickis, R.J., Wilkes, M.M., Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials. Clin Gastroenterol Hepatol 11 (2013), 123–130.
68. [68] Ha, C.E., Bhagavan, N.V., Novel insights into the pleiotropic effects of human serum albumin in health and disease. Biochim Biophys Acta 2013 (1830), 5486–5493.
69. [69] Quinlan, G.J., Martin, G.S., Evans, T.W., Albumin: biochemical properties and therapeutic potential. Hepatology 41 (2005), 1211–1219.
70. [70] Dixon, R., Brunskill, N.J., Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states. J Am Soc Nephrol 10 (1999), 1487–1497.
71. [71] Contreras, A.M., Ramirez, M., Cueva, L., Alvarez, S., de Loza, R., Gamba, G., Low serum albumin and the increased risk of amikacin nephrotoxicity. Rev Investig Clin 46 (1994), 37–43.
72. [72] Glassford, N.J., Bellomo, R., Acute kidney injury: how can we facilitate recovery?. Curr Opin Crit Care 17 (2011), 562–568.
73. [73] McDermid, R.C., Raghunathan, K., Romanovsky, A., Shaw, A.D., Bagshaw, S.M., Controversies in fluid therapy: type, dose and toxicity. World J Crit Care Med 3 (2014), 24–33.
74. [74] Garcia-Martinez, R., Noiret, L., Sen, S., Mookerjee, R., Jalan, R., Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int 35 (2015), 335–343.
75. [75] Fliser, D., Zurbruggen, I., Mutschler, E., Bischoff, I., Nussberger, J., Franek, E., et al. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55 (1999), 629–634.
76. [76] Martin, G.S., Moss, M., Wheeler, A.P., Mealer, M., Morris, J.A., Bernard, G.R., A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 33 (2005), 1681–1687.
77. [77] Uhlig, C., Silva, P.L., Deckert, S., Schmitt, J., de Abreu, M.G., Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care, 18, 2014, R10.
78. [78] Legrand, M., Dupuis, C., Simon, C., Gayat, E., Mateo, J., Lukaszewicz, A.C., et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care, 17, 2013, R278.
79. [79] Firth, J.D., Raine, A.E., Ledingham, J.G., Raised venous pressure: a direct cause of renal sodium retention in oedema?. Lancet 1 (1988), 1033–1035.
80. [80] Marik, P.E., Iatrogenic salt water drowning and the hazards of a high central venous pressure. Ann Intensive Care, 4, 2014, 21.
81. [81] Prowle, J.R., Echeverri, J.E., Ligabo, E.V., Ronco, C., Bellomo, R., Fluid balance and acute kidney injury. Nat Rev Nephrol 6 (2010), 107–115.
82. [82] Prowle, J.R., Kirwan, C.J., Bellomo, R., Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 10 (2014), 37–47.
83. [83] Gattinoni, L., Cressoni, M., Brazzi, L., Fluids in ARDS: from onset through recovery. Curr Opin Crit Care 20 (2014), 373–377.
84. [84] Dawidson, I.J., Sandor, Z.F., Coorpender, L., Palmer, B., Peters, P., Lu, C., et al. Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation 53 (1992), 774–782.